| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &COO | President &Chief Operating +3 more
2 companies
Korenberg Matthew E is a President &COO at LIGAND PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 15 sells.
Estimated insider holdings value: $11.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | LGND Ligand Pharmaceuticals Inc | President &COO | Sale+OE | 16,047 | $102.35 | $1,642,358.76 | -7.1% | +14.2% | +71.2% | |
| Aug 26, 2024 | LGND Ligand Pharmaceuticals Inc | President &COO | Sell | 18,858 | $105.34 | $1,986,420.12 | -6.0% | +14.7% | +51.9% | |
| Aug 9, 2024 | LGND Ligand Pharmaceuticals Inc | President &COO | Sell | 18,245 | $98.50 | $1,797,132.50 | -21.1% | +29.7% | +49.8% | |
| May 14, 2024 | LGND Ligand Pharmaceuticals Inc | President &Chief Operating | Sell | 17,598 | $84.99 | $1,495,740.49 | -6.0% | +16.8% | +23.2% | |
| Sep 3, 2019 | LGND Ligand Pharmaceuticals Inc | EVP,Finance &Strategy And CFO | Buy | 500 | $86.18 | $43,090.75 | +3.0% | - | - | |
| Aug 29, 2018 | LGND Ligand Pharmaceuticals Inc | EVP,Finance &Strategy And CFO | Sale+OE | 18,357 | $256.69 | $4,712,060.17 | -73.1% | - | - | |
| Nov 17, 2017 | LGND Ligand Pharmaceuticals Inc | VP, Finance And CFO | Sell | 6,559 | $142.63 | $935,510.17 | -44.6% | - | - |